Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

Clinical trial NCT00743652 · COMPLETED

Trial details

NCT number: NCT00743652
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Disease 13-valent Pneumococcal Vaccine

Start date: 2009-01-01
Primary completion: 2010-09-01
Enrollment: 373

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.